Evidence map›Paper›PMID 25620549›Full record

ArticleCell host & microbe2015

Stressed mycobacteria use the chaperone ClpB to sequester irreversibly oxidized proteins asymmetrically within and between cells.

Julien Vaubourgeix, Gang Lin, Neeraj Dhar, Nicolas Chenouard, Xiuju Jiang, Helene Botella, Tania Lupoli, Olivia Mariani, Guangli Yang, Ouathek Ouerfelli and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Article
  3. Proteostasis-targeted antibacterial strategies.Journal of microbiology (Seoul, Korea) · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Balance between asymmetric allocation and repair of somatic damage in unicellular life forms as an ancient form of r/K selection.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Eradication of Drug-TolerantMicroorganisms · 2023
    Review
  14. Types and functions of heterogeneity in mycobacteria.Nature reviews. Microbiology · 2022
    Review
  15. Article
  16. Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment.European journal of microbiology & immunology · 2022
    Review
  17. Clinically encountered growth phenotypes of tuberculosis-causing bacilli and theirFrontiers in cellular and infection microbiology · 2022
    Review
  18. Phenotypic adaptation ofFrontiers in cellular and infection microbiology · 2022
    Review
  19. Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Julien VaubourgeixDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065, USA.
Gang LinDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065, USA.
Neeraj DharSchool of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), SV 3834, Station 19, CH-1015 Lausanne, Switzerland.
Nicolas ChenouardDepartment of Physiology and Neuroscience, New York University, Langone Medical Center, New York, NY 10016, USA.
Xiuju JiangDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065, USA.
Helene BotellaDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065, USA.
Tania LupoliDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065, USA.
Olivia MarianiSchool of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), SV 3834, Station 19, CH-1015 Lausanne, Switzerland; Biomedical Imaging Group, Swiss Federal Institute of Technology in Lausanne (EPFL), BM 4.134, Station 17, CH-1015 Lausanne, Switzerland.
Guangli YangOrganic Synthesis Core Facility, Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Ouathek OuerfelliOrganic Synthesis Core Facility, Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Michael UnserBiomedical Imaging Group, Swiss Federal Institute of Technology in Lausanne (EPFL), BM 4.134, Station 17, CH-1015 Lausanne, Switzerland.
Dirk SchnappingerDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065, USA.
John McKinneySchool of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), SV 3834, Station 19, CH-1015 Lausanne, Switzerland.
Carl NathanDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: cnathan@med.cornell.edu.
Cornell University · USÉcole Polytechnique Fédérale de Lausanne · CHMemorial Sloan Kettering Cancer Center · USNYU Langone Health · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA008748-48PHS HHS R01 A1064768-09
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) defends itself against host immunity and chemotherapy at several levels, including the repair or degradation of irreversibly oxidized proteins (IOPs). To investigate how Mtb deals with IOPs that can neither be repaired nor degraded, we used new chemical and biochemical probes and improved image analysis algorithms for time-lapse microscopy to reveal a defense against stationary phase stress, oxidants, and antibiotics--the sequestration of IOPs into aggregates in association with the chaperone ClpB, followed by the asymmetric distribution of aggregates within bacteria and between their progeny. Progeny born with minimal IOPs grew faster and better survived a subsequent antibiotic stress than their IOP-burdened sibs. ClpB-deficient Mtb had a marked recovery defect from stationary phase or antibiotic exposure and survived poorly in mice. Treatment of tuberculosis might be assisted by drugs that cripple the pathway by which Mtb buffers, sequesters, and asymmetrically distributes IOPs.

Indexed as

Oxidative StressAnimalsAnti-Bacterial AgentsBacterial ProteinsEndopeptidase ClpMiceMicrobial ViabilityMycobacterium tuberculosisOxidantsOxidation-ReductionProtein AggregatesProtein MultimerizationProtein Processing, Post-TranslationalProtein TransportAnti-Bacterial AgentsBacterial ProteinsEndopeptidase ClpOxidantsProtein Aggregates

Identifiers

PMID25620549
PMCPMC5707119
OpenAlexW1964384820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.